Skip to content

Myofascial Release Technique in Women With Primary Dysmenorrhea

Effect of Myofascial Release Technique on Central Sensitization, Myofascial Trigger Point and Menstrual Symptoms in Women With Primary Dysmenorrhea: Sham-Controlled, Randomized Double-Blind Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06492148
Enrollment
36
Registered
2024-07-09
Start date
2024-09-10
Completion date
2025-09-25
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Sensitisation, Dysmenorrhea Primary, Menstrual Discomfort, Myofascial Release, Myofascial Trigger Point Pain

Keywords

myofascial release, trigger point, Central sensitization, Dysmenorrhea, sham

Brief summary

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Detailed description

During the evaluation period, the participants' musculoskeletal pain threshold and tolerance will be measured using an algometer, about trigger points on the identified muscles (rectus abdominis, quadratus lumborum, erector spinae, and tibialis anterior). A total of 40 women, aged 18-40, diagnosed with primary dysmenorrhea by a gynecologist, will be included in the study. The initial assessment of the participants will be conducted on their most painful days. Participants will be randomized into two groups: the myofascial release technique group (study group) and the placebo myofascial release technique group (control group). The interventions will be conducted over 10 sessions during one menstrual cycle, and all evaluations will be repeated after the treatment period. The study will be conducted as a double-blind trial, ensuring that both the evaluators and the patients are blind to the group assignments.

Interventions

OTHERMyofascial Release

The myofascial release technique is a widely used manual therapy method characterized by low-load, prolonged mechanical forces applied to manipulate the myofascial complex, aiming to restore optimal length, alleviate pain, and improve function.

OTHERSham-Myofascial Release

The hands of the researcher applying the technique will be placed in the same areas as the myofascial release technique, with only the palms in light contact for the same duration. However, no intervention will be made to create any pressure or open the tissue barrier.

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide, * Having regular menstruation in the last 6 months (28±7 days) * Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months

Exclusion criteria

* Diagnosed with Secondary Dysmenorrhea, * Having given birth, * Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes, * Undergoing urogynecological surgery, * Those who are pregnant or suspected of pregnancy, * Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain, * Those using intrauterine or oral contraceptives, * Those taking extra supplements such as magnesium, which may affect treatment

Design outcomes

Primary

MeasureTime frameDescription
Pain Pressure ThresholdBaseline (First menstruation cycle)Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.
Central SensitizationBaseline (First menstruation cycle)Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.
Menstrual pain intensityBaseline (First menstruation cycle)Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.

Secondary

MeasureTime frameDescription
Menstrual AttitudeBaseline (First menstruation cycle)Menstrual Attitude Scale will be used to evaluate symptoms related to menstruation. High scores indicate a high awareness of menstruation.
The Body AwarenessBaseline (First menstruation cycle)The Body Awareness Questionnaire will be used to evaluate changes in individuals' body awareness. The questionnaire consists of 18 items and 4 subscales (predicting body reactions, sleep-wake cycle, predicting the onset of the disease, paying attention to changes in body processes).
Health-related quality of lifeBaseline (First menstruation cycle)Short Form (SF-36) will be used to evaluate individuals' general health-related quality of life. SF-36 is a 36-question survey that evaluates functionality and well-being and consists of 8 subscales. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Higher scores indicate a better quality of life.
AnxietyBaseline (First menstruation cycle)State and Trait Anxiety Scale is a self-assessment inventory that evaluates anxiety and consists of 40 items.

Countries

Turkey (Türkiye)

Contacts

Primary ContactResearch Asisstant
beyzayazgan@gazi.edu.tr+905535134631

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026